Search research articles
Contact Us
Filters
Showing results (21-30 of 33) with videos related to
Page
of 4
Sort By:
The Lancet. Oncology
|
November 3, 2022
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Neuro-Oncology
|
February 13, 2007
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report
Ian F Pollack, Regina I Jakacki, Susan M Blaney, et al.
Ecology
|
July 13, 2018
WASPnest: a worldwide assessment of social Polistine nesting behavior
Sara E Miller, Sarah E Bluher, Emily Bell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2021
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE
Andrew Dj Pearson, Steven G DuBois, Vickie Buenger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Andrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Andrew D J Pearson, Elly Barry, Yael P Mossé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
The Lancet. Oncology
|
April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 33) with videos related to
Sort By:
Page
of 4
The Lancet. Oncology
|
November 3, 2022
ACCELERATE Paediatric Strategy Forums: an advance for oncological drug development?
Andrew D J Pearson, Teresa de Rojas, Dominik Karres, et al.
Neuro-Oncology
|
February 13, 2007
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report
Ian F Pollack, Regina I Jakacki, Susan M Blaney, et al.
Ecology
|
July 13, 2018
WASPnest: a worldwide assessment of social Polistine nesting behavior
Sara E Miller, Sarah E Bluher, Emily Bell, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2021
Bromodomain and extra-terminal inhibitors-A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children-ACCELERATE
Andrew Dj Pearson, Steven G DuBois, Vickie Buenger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 18, 2019
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
Andrew D J Pearson, Nicole Scobie, Koenraad Norga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
Andrew D J Pearson, Elly Barry, Yael P Mossé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
Andrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
The Lancet. Oncology
|
April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis
Andrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
Page
of 4